[1]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版) [J]. 中华糖尿病杂志, 2014, 4(7): 447-498.
|
[2]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版) [J]. 中华糖尿病杂志, 2018, 10(1): 4-67.
|
[3]
|
彭芳, 张洋. 糖尿病足患者感染多重耐药菌的病原学分布特点与危险因素临床效果评价[J]. 中国保健营养, 2020, 30(5): 96-97.
|
[4]
|
Hingorani, A., Lamuraglia, G.M., Henke, P., et al. (2016) The Management of Diabetic Foot: A Clinical Practice Guideline by the Society for Vascular Surgery in Collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of Vascular Surgery, 63, 3-21. https://doi.org/10.1016/j.jvs.2015.10.003
|
[5]
|
Demirdal, T. and Sen, P. (2018) The Significance of Neutro-phil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Lymphocyte-Monocyte Ratio in Predicting Peripheral Arterial Disease, Peripheral Neuropathy, Osteomyelitis and Amputation in Diabetic Foot Infection. Diabetes Research and Clini-cal Practice, 144, 118-125.
https://doi.org/10.1016/j.diabres.2018.08.009
|
[6]
|
Ong, E., Farran, S., Salloum, M., et al. (2017) Does Everything That’s Counted Count? Value of Inflammatory Markers for Following Therapy and Predicting Outcome in Diabetic Foot Infection. The International Journal of Lower Extremity Wounds, 16, 104-107. https://doi.org/10.1177/1534734617700539
|
[7]
|
Li, X., Xiao, T., Wang, Y., et al. (2011) Incidence, Risk Factors for Amputation among Patients with Diabetic Foot Ulcer in a Chinese Tertiary Hospital. Diabetes Research and Clinical Practice, 93, 26-30.
https://doi.org/10.1016/j.diabres.2011.03.014
|
[8]
|
Bakker, K., Schaper, N.C., on Behalf of the Intenational Work-ing Group on Diabetic Foot Editorial Board (2012) The Development of Global Consensus Guidelines on the Manage-ment and Prevention of the Diabetic Foot 2011. Diabetes/Metabolism Research and Reviews, 28, 116-118. https://doi.org/10.1002/dmrr.2254
|
[9]
|
赵晨旭, 周慧敏.《中国糖尿病足诊治指南》解读[J]. 中国临床医生杂志, 2021, 49(12): 1405-1408.
|
[10]
|
Rhim, B. and Harkless, L. (2012) Prevention: Can We Stop Problems before They Arise. Seminars in Vascular Surgery, 25, 122-128. https://doi.org/10.1053/j.semvascsurg.2012.05.002
|
[11]
|
管珩, 刘志民, 李光伟, 等. 50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J]. 中华医学杂志, 2007, 87(1): 23-27.
|
[12]
|
王爱红, 许樟荣, 王玉珍, 等. 有心血管危险因素的老年糖尿病患者有更高的下肢动脉病变患病率[J]. 老年医学与保健, 2005, 11(3): 147-149, 259.
|
[13]
|
Jiang, Y., Wang, X., Xia, L., et al. (2015) A Cohort Study of Diabetic Patients and Diabetic Foot Ulceration Patients in China. Wound Repair and Regeneration, 23, 222-230. https://doi.org/10.1111/wrr.12263
|
[14]
|
Jiang, Y., Ran, X., Jia, L., et al. (2015) Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China. The International Journal of Lower Extremity Wounds, 14, 19-27.
https://doi.org/10.1177/1534734614564867
|
[15]
|
Wagner, F.W. (1981) The Dysvascular Foot: A System of Diag-nosis and Treatment. Foot & Ankle International, 2, 64-122. https://doi.org/10.1177/107110078100200202
|
[16]
|
中国微循环学会周围血管疾病专业委员会糖尿病足学组. 糖尿病足创面修复治疗专家共识[J]. 中华糖尿病杂志, 2018, 10(5): 305-309.
|
[17]
|
Alejandra, B.M., José Patricio, L.P., Blanca, V.A., et al. (2018) Inter-Observer Agreement of the Wagner, University of Texas and PEDIS Classification Systems for the Diabetic Foot Syndrome. Foot and Ankle Surgery, 24, 60-64.
https://doi.org/10.1016/j.fas.2016.10.009
|
[18]
|
陈文秀, 仇海燕. 糖尿病足评估工具的研究进展[J]. 护理研究, 2018, 32(21): 3367-3369
|
[19]
|
Piaggesi, A. and Apelqvist, J. (2017) The Diabetic Foot Syndrome Today: A Pandemic Uprise. Frontiers in Diabetes, 26, 1-18. https://doi.org/10.1159/000480040
|
[20]
|
Ogurtsova, K., Morbach, S., Haastert, B., et al. (2021) Cumulative Long-Term Recurrence of Diabetic Foot Ulcers in Two Cohorts from Centresin Germany and the Czech Republic. Diabetes Research and Clinical Practice, 172, Article ID: 108621. https://doi.org/10.1016/j.diabres.2020.108621
|
[21]
|
关小宏. 糖尿病足病的治疗与预防[J]. 中华损伤与修复杂志(电子版), 2015(2): 98-102.
|
[22]
|
付小兵. 对组织再生和再生医学发展的再思考[J]. 中华烧伤杂志, 2011, 27(1): 1-2.
|
[23]
|
Richard, J.L., Lavigne, J.P., Got, I., et al. (2011) Management of Patients Hospitalized for Diabetic Foot Infec-tion: Results of the French OPIDIA study. Diabetes & Metabolism, 37, 208-215.
https://doi.org/10.1016/j.diabet.2010.10.003
|
[24]
|
Atak, B., Aktas, G., Duman, T.T., et al. (2019) Diabetes Control Could through Platelet-to-Lymphocyte Ratio in Hemograms. Revista da Associacao Medica Brasileira, 65, 38-42. https://doi.org/10.1590/1806-9282.65.1.38
|
[25]
|
Mertoglu, C. and Gunay, M. (2017) Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio as Useful Predictive Markers of Prediabetes and Diabetes Mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 11, S127-S131. https://doi.org/10.1016/j.dsx.2016.12.021
|
[26]
|
郎亦波, 叶燕芹. 中性粒细胞/淋巴细胞比值对2型糖尿病肾病的诊断价值[J]. 实用检验医师杂志, 2019, 11(4): 224-226
|
[27]
|
刘小静. 临床糖尿病诊断中常规检验和生化检验的应用价值[J]. 中国保健营养, 2021, 31(14): 11.
|
[28]
|
Akbas, E.M., Demirtas, L., Ozcicek, A., Timuroglu, A., et al. (2014) Association of Epicardial Adipose Tissue, Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Nephropathy. International Journal of Clinical and Experimental Medicine, 7, 1794-1801.
|
[29]
|
任焕欣, 吴晓明, 赵伟, 等. 外周血血小板与淋巴细胞比值和2型糖尿病肾病的相关性研究[J]. 中华内分泌代谢杂志, 2015, 31(5): 406-407.
|
[30]
|
黄冉冉, 徐英英, 陈矢. 比较中性粒细胞/淋巴细胞、血小板/淋巴细胞和平均血小板体积对早期糖尿病肾病的预测价值[J]. 中华内分泌外科杂志, 2019, 13(1): 76-80.
|
[31]
|
Kern, T.S. (2007) Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy. Journal of Diabetes Research, 2007, Article ID: 095103. https://doi.org/10.1155/2007/95103
|
[32]
|
Wang, J., Chen, Z., Yang, Y., Yang, K., et al. (2020) Association between Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Diabetic Retinopathy among Diabetic Patients with-out a Related Family History. (Preprint) https://doi.org/10.21203/rs.3.rs-24133/v1
|
[33]
|
韦玉, 管世鹤, 周强, 等. 血小板与淋巴细胞比值在糖尿病视网膜病变中的诊断价值[J]. 安徽医科大学学报, 2017, 52(3): 409-411+449.
|
[34]
|
郭慧娟, 李天艺, 李媛媛. 全身免疫炎症指数与中老年2型糖尿病患者颈动脉不稳定斑块的相关性及其预测价值[J]. 河南医学研究, 2023, 32(2): 222-226.
|
[35]
|
卢厚新, 郭石, 杨清泉, 刘煜昊, 吴超群. 术前血清学炎症指标对急性心肌梗死患者PCI术后生存时间的评价及炎症标志物构建[J]. 中国老年学杂志, 2023, 43(2): 257-262.
|
[36]
|
耿一凡, 吴萌, 江波, 韩正祥, 杜秀平. PIV、NLR、PLR、MLR对晚期非小细胞肺癌免疫治疗近期疗效和预后的评估价值[J]. 现代生物医学进展, 2023, 23(1): 163-167. https://doi.org/10.13241/j.cnki.pmb.2023.01.032
|
[37]
|
Onalan, E., Gozel, N. and Donder, E. (2019) Can Hemato-logical Parameters in Type 2 Diabetes Predict Microvascular Complication Development? Pakistan Journal of Medical Sciences, 35, 1511-1515.
https://doi.org/10.12669/pjms.35.6.1150
|
[38]
|
董荣静, 石柔, 董雪娥, 等. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与2型糖尿病患者颈动脉粥样硬化的相关性[J]. 中华临床医师杂志(电子版), 2017, 11(2): 179-182.
|
[39]
|
张新, 王玲, 王世蓉, 等. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及同型半胱氨酸与2型糖尿病患者冠心病的关系研究[J]. 实用心脑肺血管病杂志, 2019, 27(6): 44-47.
|
[40]
|
白超, 杨雯雯, 罗军. 红细胞体积分布宽度和中性粒细胞与淋巴细胞比值联合预测糖尿病足的预后[J]. 中国临床研究, 2021, 34(5): 596-599. https://doi.org/10.13429/j.cnki.cjcr.2021.05.005
|
[41]
|
胡馨莉, 翁孝刚. MHR、LMR对2型糖尿病患者合并代谢综合征的诊断价值[J]. 河南医学研究, 2020, 29(23): 4257-4260.
|
[42]
|
王琼, 胡红琳, 王佑民. 淋巴细胞/单核细胞与2型糖尿病颈动脉粥样硬化严重程度的相关性研究[J]. 中国心血管病研究, 2023, 21(1): 50-55.
|
[43]
|
丁胜兰, 邓书华, 程庆丰, 熊淑媛, 刘智平. 血小板/淋巴细胞比值及中性粒细胞/淋巴细胞比值与糖尿病足感染患者骨髓炎及截肢的相关性研究[J]. 中国糖尿病杂志, 2020, 28(7): 510-516.
|
[44]
|
郑美洁, 李贤, 高哲, 等. 血小板/淋巴细胞比值和C-反应蛋白与糖尿病足溃疡严重程度及预后的关系[J]. 中国临床研究, 2022, 35(7): 938-942+947. https://doi.org/10.13429/j.cnki.cjcr.2022.07.010
|
[45]
|
Zubair, M. (2020) Prevalence and Interrela-tionships of Foot Ulcer, Risk-Factors and Antibiotic Resistance in Foot Ulcers in Diabetic Populations: A Systematic Re-view and Meta-Analysis. World Journal of Diabetes, 11, 78-89.
https://doi.org/10.4239/wjd.v11.i3.78
|
[46]
|
Hicks, C.W., Canner, J.K., Mathioudakis, N., et al. (2020) Incidence and Risk Factors Associated with Ulcer Recurrence among Patients with Diabetic Foot Ulcers Treated in a Multidiscipli-nary Setting. Journal of Surgical Research, 246, 243-250. https://doi.org/10.1016/j.jss.2019.09.025
|
[47]
|
陈燕, 张蓓华. 上海市 ≥ 60岁2型糖尿病患者下肢溃疡现状及影响因素[J]. 华南预防医学, 2020, 46(3): 294-296.
|
[48]
|
顾淑君, 张秋伊, 周正元, 等. 糖化血红蛋白变异指数与2型糖尿病患者糖尿病慢性并发症的相关性研究[J]. 华南预防医学, 2021, 47(4): 431-435.
|